DLBCL Clinical Trials: Overview of L-MIND and RE-MIND2

News
Video

Matthew Lunning, DO, FACP, further explores relapsed/refractory DLBCL treatment strategies and clinical trial findings from the L-MIND and RE-MIND2 studies, discussing the impact of tafasitamab + lenalidomide on patient outcomes.

Related Videos
Brooke Peters, PharmD, BCOP, a clinical pharmacist
Expert on DLBCL
Expert on DLBCL
Expert on DLBCL
Expert on DLBCL
Expert on DLBCL
Expert on DLBCL
Rafael Fonseca, MD, smiles at the camera on a white-and-yellow background.
Related Content